Please assess the completion status of the following clinical trial:

Trial Title: Study of AK156 in Primary Osteoporosis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with primary osteoporosis~* Patients who have vertebral fractures at the time of screening~Exclusion Criteria:~* Patients diagnosed with secondary osteoporosis~* Patients with a current uncontrolled medical disorder or other condition which makes the patient unsuitable for the study

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- 1. (Type: EXPERIMENTAL): None
- 2. (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).